| 101 |
12030736 | Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. | 2002 May |
1 |
| 102 |
12200524 | Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose. | 2002 Sep |
1 |
| 103 |
12215911 | [Onset of action of formoterol in patients with moderate to severe, partially reversible airflow obstruction assessed by bodyplethysmography]. | 2002 Sep |
1 |
| 104 |
12222549 | Formoterol therapy for chronic obstructive pulmonary disease: a review of the literature. | 2002 Sep |
1 |
| 105 |
12396417 | In vitro testing of two formoterol dry powder inhalers at different flow rates. | 2002 Fall |
1 |
| 106 |
12510953 | From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma. | 2002 Dec |
1 |
| 107 |
12510955 | Symbicort Turbuhaler: a new concept in asthma management. | 2002 Dec |
1 |
| 108 |
12561417 | Regulation of calcium homeostasis in activated human neutrophils--potential targets for anti-inflammatory therapeutic strategies. | 2002 Dec |
1 |
| 109 |
14720033 | Beta2-agonist eutomers: a rational option for the treatment of asthma? | 2002 |
1 |
| 110 |
14720076 | Long-acting beta2-agonists: comparative pharmacology and clinical outcomes. | 2002 |
1 |
| 111 |
11217872 | Inhaled budesonide/formoterol combination. | 2001 |
1 |
| 112 |
11293649 | Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists? | 2001 |
1 |
| 113 |
11405513 | Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol. | 2001 Mar |
1 |
| 114 |
11421509 | Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study. | 2001 Jun |
3 |
| 115 |
11453313 | Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. | 2001 Jul |
2 |
| 116 |
11463597 | Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer. | 2001 Jul 15 |
1 |
| 117 |
11534892 | The evolution of beta2-agonists. | 2001 Aug |
2 |
| 118 |
11534893 | Formoterol in clinical practice--safety issues. | 2001 Aug |
1 |
| 119 |
11534895 | Formoterol--where does it fit in the current guidelines? | 2001 Aug |
1 |
| 120 |
11534896 | Pharmacological similarities and differences between beta2-agonists. | 2001 Aug |
2 |
| 121 |
11589265 | Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial. | 2001 Sep |
2 |
| 122 |
11594259 | Clinical efficacy with formoterol in the absence of a response to salmeterol: a review. | 2001 Sep |
1 |
| 123 |
11791690 | In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler. | 2001 Winter |
1 |
| 124 |
16263481 | Beta2-adrenoceptors: mechanisms of action of beta2-agonists. | 2001 Mar |
1 |
| 125 |
10608425 | New millennium bronchodilators for asthma: single-isomer beta agonists. | 2000 Jan |
1 |
| 126 |
10783649 | [Effect of the long-acting beta-2 agonist inhalant formoterol on the quality of sleep of patients with bronchial asthma]. | 2000 Mar |
2 |
| 127 |
10983735 | Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease. | 2000 Aug |
1 |
| 128 |
10091511 | [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma]. | 1999 Jan |
1 |
| 129 |
10335908 | Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer. | 1999 Apr |
1 |
| 130 |
10351919 | Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. | 1999 Jun |
1 |
| 131 |
10354365 | Glucocorticoids augment fibroblast-mediated contraction of collagen gels by inhibition of endogenous PGE production. | 1999 May-Jun |
1 |
| 132 |
10540564 | [Dry powdered formoterol, twice a day versus aerosolized salbutamol, four times a day, in patients with stable asthma]. | 1999 Sep-Oct |
1 |
| 133 |
10596687 | Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. | 1999 Nov |
1 |
| 134 |
9506248 | Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. | 1998 Feb |
3 |
| 135 |
9759798 | A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study. | 1998 Sep |
2 |
| 136 |
9762783 | Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol. | 1998 Sep |
1 |
| 137 |
9817738 | The beta-adrenoceptor. | 1998 Nov |
1 |
| 138 |
10195069 | Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. | 1998 Dec |
1 |
| 139 |
10622090 | Long-acting inhaled beta 2-agonists in the management of asthma: recent advances and current recommendations. | 1998 Oct |
1 |
| 140 |
9131836 | [Foradil p (Formoterol)--a new long-acting beta2-sympathomimetic for inhalation]. | 1997 Feb |
1 |
| 141 |
9187530 | Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern? | 1997 May |
1 |
| 142 |
9227720 | Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. | 1997 Jun |
2 |
| 143 |
9230722 | Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. | 1997 Jul |
1 |
| 144 |
9248317 | Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. | 1997 May |
1 |
| 145 |
9282409 | Using beta 2-stimulants in asthma. | 1997 Jan |
1 |
| 146 |
9316102 | Managing symptoms and exacerbations in pediatric asthma. | 1997 Sep |
1 |
| 147 |
9426083 | Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. | 1997 Nov |
2 |
| 148 |
8630591 | Functional and binding characteristics of long-acting beta 2-agonists in lung and heart. | 1996 May |
2 |
| 149 |
8658370 | Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol. | 1996 Jan |
6 |
| 150 |
9438143 | Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma. | 1996 Jul 25 |
1 |